ASXL1 and myelodysplastic syndrome: Mossner et al. [33] showed that mutations affecting epigenetic modifiers (e.g., TET2 and ASXL1) and RNA splicing factors (e.g., SF3B1 and SRSF2) are predominantly “founder” events in MDS [33].